Agomelatine versus desvenlafaxine versus bupropion XR in the treatment of anhedonia in major depressive disorder

被引：1
|
作者：
Romero Guillena, S. L. [1 ]
Plasencia Garcia de Diego, B. O. [2 ]
Mata Saenz, B. O. [3 ]
机构：
[1] Area Hosp Virgen Macarena, UGC Salud Mental, USMC Carmona, Seville, Spain
[2] De la Merced Hosp, Dept Psychiat, Osuna, Spain
[3] Area Hosp Virgen Macarena, UGC Salud Mental, Osuna, Spain
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
VENLAFAXINE XR;
D O I：
10.1016/S0924-977X(14)70738-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.f.017
引用
收藏
页码：S461 / S462
页数：2
相关论文
共 50 条
  • [1] Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder A Pilot Study
    Martinotti, Giovanni
    Sepede, Gianna
    Gambi, Francesco
    Di Iorio, Giuseppe
    De Berardis, Domenico
    Di Nicola, Marco
    Onofrj, Marco
    Janiri, Luigi
    Di Giannantonio, Massimo
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (04) : 487 - 491
  • [2] Antidepressant for major depressive disorder. Comparison with vortioxetine, agomelatine, desvenlafaxine and bupropion XR
    Plasencia Garcia de Diego, B. O.
    Romero Guillena, S. L.
    Navarro Pablo, R.
    Gotor Sanchez-Luengo, F.
    Santamaria Gomez, O.
    EUROPEAN PSYCHIATRY, 2018, 48 : S205 - S206
  • [3] AGOMELATINE VERSUS VENLAFAXINE IN THE TREATMENT OF ANHEDONIA IN MAJOR DEPRESSIVE SUBJECTS: A PILOT STUDY
    Martinotti, G.
    Sepede, G.
    Di Nicola, M.
    Di Iorio, G.
    Gambi, F.
    De Risio, L.
    Janiri, L.
    Di Giannantonio, M.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [4] Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland
    Soini, Erkki
    Hallinen, Taru
    Brignone, Melanie
    Campbell, Rosanne
    Diamand, Francoise
    Cure, Sandrine
    Aalto-Setala, Maria
    Danchenko, Natalya
    Koponen, Hannu
    Kolasa, Katarzyna
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (03) : 293 - 302
  • [5] Venlafaxine XR versus escitalopram treatment of major depressive disorder
    Zarra, J
    Schmidt, L
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S394 - S395
  • [6] Escitalopram versus venlafaxine XR in the treatment of major depressive disorder
    Montgomery, S.
    Andersen, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S233 - S233
  • [7] Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder
    Atkinson, Sarah
    Lubaczewski, Shannon
    Ramaker, Sara
    England, Richard D.
    Wajsbrot, Dalia B.
    Abbas, Richat
    Findling, Robert L.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (01) : 55 - 65
  • [8] COST-UTILITY ANALYSIS EVALUATING VORTIOXETINE VERSUS VENLAFAXINE XR AND AGOMELATINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN TAIWAN
    Brignone, M.
    Atsou, K.
    Reynaud-Mougin, C.
    Chen, W.
    Milea, D.
    VALUE IN HEALTH, 2016, 19 (07) : A841 - A842
  • [9] Sertraline versus venlafaxine XR in major depressive disorder
    Lusicic, Ana
    Jagadheesan, Karuppiah
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (10) : 1618 - 1619
  • [10] Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder
    Huang, Juan
    Xie, Xiao-Meng
    Lyu, Nan
    Fu, Bing-Bing
    Zhao, Qian
    Zhang, Ling
    Wang, Gang
    FRONTIERS IN PSYCHIATRY, 2023, 14
12345